Avior Wealth Management’s ANI Pharmaceuticals ANIP Stock Holding History

Avior Wealth Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1	Closed	-$59	–	2467
2024 Q3	$59	Buy	+1	New	+$61	﹤0.01%	2276
2024 Q2	–	Sell	-3	Closed	-$207	–	2333
2024 Q1	$207	Buy	+3	New	+$181	﹤0.01%	2862
2020 Q4	–	Sell	-765	Closed	-$21K	–	967
2020 Q3	$21K	Hold	765	–	–	﹤0.01%	584
2020 Q2	$24K	Hold	765	–	–	﹤0.01%	548
2020 Q1	$31K	Hold	765	–	–	0.01%	484
2019 Q4	$47K	Hold	765	–	–	0.01%	466
2019 Q3	$55K	Hold	765	–	–	0.01%	451
2019 Q2	$63K	Hold	765	–	–	0.01%	437
2019 Q1	$53K	Hold	765	–	–	0.01%	427
2018 Q4	$34K	Hold	765	–	–	0.01%	487
2018 Q3	$43K	Hold	765	–	–	0.01%	493
2018 Q2	$51K	Buy	+765	New	+$47.8K	0.01%	482

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Avior Wealth Management's ANIP Position: Q4 2024 in Review

Avior Wealth Management sold out of ANI Pharmaceuticals (ANIP) in Q4 2024, closing a stake of 1 share — an estimated $59 sold.

Avior Wealth Management first reported a position in ANIP in Q2 2018 and held it in 12 quarters. The position peaked at $63K in Q2 2019. 205 funds tracked by Wall St. Rank hold ANIP as of Q4 2024.

Avior Wealth Management reported no remaining ANI Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Avior Wealth Management sold 1 ANI Pharmaceuticals share in Q4 2024, an estimated $59.
Avior Wealth Management first reported a position in ANI Pharmaceuticals in Q2 2018 and held it in 12 quarters.
Avior Wealth Management's ANI Pharmaceuticals position peaked at $63K in Q2 2019.
205 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2024.

Based on Avior Wealth Management's 13F filing for Q4 2024, filed 17 Jan 2025.